Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines
PEARL (University of Plymouth) · 08.08.2024
DOI: 10.24382/6qvr-w034 ↗Kurz gefasst
Fachartikel in der Zeitschrift PEARL (University of Plymouth), erschienen am 08.08.2024. Verfasst von Medeiros und 1 weiteren Autor:innen.
Abstract (Originalsprache)
The oral antidiabetic, metformin, has been documented to have antineoplastic activity in various cancer cell lines, associated with the inhibition of mitochondrial complex I. However, pre-clinical studies have struggled to demonstrate such antineoplastic activity utilising metformin concentrations attainable with standard antidiabetic dosing. Research has revealed that metformin combined with the anti-hypertensive drug, syrosingopine, lowers metformin’s therapeutic threshold and sensitizes cancer cells to killing, by inhibiting monocarboxylate transporters (MCT)1/MCT4. The potent interaction between these drugs elicits a synthetic lethality, specific to transformed cells. This preliminary study aimed to investigate metformin’s antineoplastic effects and its synergistic relationship with syrosingopine by measuring cell viability and extracellular lactate in PC3 (adherent) and THP-1 (suspension) cancer cell lines. Overall, the PC3 cell line responded better to treatment with combined doses of metformin and syrosingopine, or either drug alone; however, synthetic lethality was not observed in either cell line. In both cell lines, the interaction between metformin and syrosingopine was not statistically significant in the cell viability assays (p>0.05). Analysis of MCT1/MCT4 inhibition through the measurement of extracellular lactate was not statistically significant (p>0.05) and proved inconclusive. Additionally, the nature of the cell line, adherent or suspension, was statistically significant (p
Schlagwörter
Zitieren
APA
Medeiros, & Sophia (2024). Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines. PEARL (University of Plymouth). https://doi.org/10.24382/6qvr-w034
Vancouver
Medeiros, Sophia. Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines. PEARL (University of Plymouth). 2024. doi:10.24382/6qvr-w034
BibTeX
@article{Medeiros2024,
author = {Medeiros and Sophia},
title = {Investigating Metformin & Syrosingopine's Synthetic Lethality in PC3 & THP-1 Cancer Cell Lines},
journal = {PEARL (University of Plymouth)},
year = {2024},
doi = {10.24382/6qvr-w034}
}
EUVIMED